rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Baird Medical Investment Holdings Ltd - Ordinary Share

BDMD · Nasdaq

Health CareMedical DevicesNot moving yet

BDMD stood above a rising 150-day average in 2 of the last 52 weekly readings, and has been out of that trend for the last 29 weeks. It is 57.1% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 29
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
25 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders25+1 on the quarter
New · exited1 · 0
Reported value$225K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Clear Street Group Inc.unchanged · filed 12 Aug 2026775,488$31K00.0%
Sculptor Capital LPunchanged · filed 14 Aug 2026700,000$33K00.0%
ARISTEIA CAPITAL, L.L.C.unchanged · filed 14 Aug 2026570,992$27K00.0%
Calamos Advisors LLCunchanged · filed 31 Jul 2026500,000$25K00.0%
Linden Advisors LPunchanged · filed 14 Aug 2026435,179$21K00.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.unchanged · filed 14 Aug 2026375,000$15K00.0%
Davidson Kempner Capital Management LPunchanged · filed 14 Aug 2026250,000$10K00.0%
GOLDMAN SACHS GROUP INCunchanged · filed 14 Aug 2026220,004$8,88800.0%
TORONTO DOMINION BANKunchanged · filed 14 Aug 2026160,933$6,43700.0%
D. E. Shaw & Co., Inc.unchanged · filed 14 Aug 2026150,000$6,10500.0%
31 Dec 2024 – 30 Jun 2026
242627Dec 24Jun 25Sep 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202583.8%
Operating profit marginFY 2025 · to 31 Dec 2025-114%
Free cash flow marginFY 2025 · to 31 Dec 2025-6.2%
Return on capital employedFY 2025 · to 31 Dec 2025-68.6%
Debt to equityFY 2025 · to 31 Dec 20250.36×
Interest coverFY 2025 · to 31 Dec 2025-72.33×
Research spendFY 2025 · to 31 Dec 202589.3%
Revenue growthFY 2025 · to 31 Dec 2025-39.2%
Earnings per share growthFY 2025 · to 31 Dec 2025-300%
Share count trendFY 2025 · to 31 Dec 2025-13.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$178K
Free cash flowFY 2025 · to 31 Dec 2025−$1.4M

Analyst forecasts

No analyst forecasts yet.